Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsMerck's Ebola Vaccine Is 'Highly Effective'
Merck's Ebola Vaccine Is 'Highly Effective'
by Bloomberg Video 2:54 mins
July 31 -- Merck & Co.s vaccine for Ebola is highly effective, according to an interim analysis from a panel of experts who recommended that a late-stage trial should continue.
http://finance.yahoo.com/video/ebola-vaccine-highly-effective-trial-131449674.html
InfoView thread info, including edit history
TrashPut this thread in your Trash Can (My DU » Trash Can)
BookmarkAdd this thread to your Bookmarks (My DU » Bookmarks)
4 replies, 541 views
ShareGet links to this post and/or share on social media
AlertAlert this post for a rule violation
PowersThere are no powers you can use on this post
EditCannot edit other people's posts
ReplyReply to this post
EditCannot edit other people's posts
Rec (8)
ReplyReply to this post
4 replies
= new reply since forum marked as read
Highlight:
NoneDon't highlight anything
5 newestHighlight 5 most recent replies
Merck's Ebola Vaccine Is 'Highly Effective' (Original Post)
still_one
Jul 2015
OP
NuclearDem
(16,184 posts)1. Terrific!
haikugal
(6,476 posts)2. That's very good news! nt
Spazito
(50,486 posts)3. This is wonderful news! BIG thanks to the Canadian researchers at...
the Public Health Agency of Canada's National Microbiology Laboratory in Winnipeg under the direction of Dr. Gary Kobinger!
Ebola vaccine from Canada seems to work in trial in Guinea: WHO
http://www.cbc.ca/news/health/ebola-vaccine-from-canada-seems-to-work-in-trial-in-guinea-who-1.3175101
My Pet Goat
(413 posts)4. Nearly 100% effective in early trials.